Global Pertussis Vaccine Sales Market Report 2021

Global Pertussis Vaccine Sales Market Report 2021

Table of Contents
1 PERTUSSIS VACCINE MARKET OVERVIEW 1
1.1 Pertussis Vaccine Product Scope 1
1.2 Pertussis Vaccine Segment by Type 1
1.2.1 Global Pertussis Vaccine Revenue by Type (2016 & 2021 & 2027) 2
1.2.2 Acellular Vaccines 2
1.2.3 Whole-cell Vaccines 3
1.3 Pertussis Vaccine Segment by Application 4
1.3.1 Global Pertussis Vaccine Revenue Comparison by Application (2016 & 2021 & 2027) 4
1.3.2 12 Months Below 5
1.3.3 12 Months Above 6
1.4 Global Pertussis Vaccine Market Estimates and Forecasts (2016-2027) 7
1.4.1 Global Pertussis Vaccine Market Size in Value Growth Rate (2016-2027) 7
1.4.2 Global Pertussis Vaccine Market Size in Volume Growth Rate (2016-2027) 9
1.4.3 Global Pertussis Vaccine Price Trends (2016-2027) 10
2 PERTUSSIS VACCINE ESTIMATES AND FORECASTS BY REGION 11
2.1 Global Pertussis Vaccine Market Size by Region: 2016 VS 2021 VS 2027 11
2.2 Global Pertussis Vaccine Retrospective Market Scenario by Region (2016-2021) 12
2.2.1 Global Pertussis Vaccine Sales Market Share by Region (2016-2021) 12
2.2.2 Global Pertussis Vaccine Revenue Market Share by Region (2016-2021) 13
2.3 Global Pertussis Vaccine Market Estimates and Forecasts by Region (2022-2027) 15
2.3.1 Global Pertussis Vaccine Sales Estimates and Forecasts by Region (2022-2027) 15
2.3.2 Global Pertussis Vaccine Revenue Forecast by Region (2022-2027) 16
2.4 Geographic Market Analysis: Market Facts & Figures 18
2.4.1 North America Pertussis Vaccine Estimates and Projections (2016-2027) 18
2.4.2 Europe Pertussis Vaccine Estimates and Projections (2016-2027) 20
2.4.3 China Pertussis Vaccine Estimates and Projections (2016-2027) 22
2.4.4 Japan Pertussis Vaccine Estimates and Projections (2016-2027) 24
2.4.5 India Pertussis Vaccine Estimates and Projections (2016-2027) 26
2.4.6 Asia-Pacific Other Pertussis Vaccine Estimates and Projections (2016-2027) 28
3 PERTUSSIS VACCINE COMPETITION LANDSCAPE BY PLAYERS 30
3.1 Global Pertussis Vaccine Players by Sales (2016-2021) 30
3.2 Global Pertussis Vaccine Players by Revenue (2016-2021) 31
3.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2020) 33
3.4 Global Pertussis Vaccine Average Price by Company (2016-2021) 34
3.5 Pertussis Vaccine Manufacturers Headquarters 34
4 PERTUSSIS VACCINE MARKET SIZE BY TYPE 35
4.1 Global Pertussis Vaccine Historic Market Review by Type (2016-2021) 35
4.1.1 Global Pertussis Vaccine Sales Market Share by Type (2016-2021) 35
4.1.2 Global Pertussis Vaccine Revenue Market Share by Type (2016-2021) 36
4.1.3 Global Pertussis Vaccine Price by Type (2016-2021) 37
4.2 Global Pertussis Vaccine Market Estimates and Forecasts by Type (2022-2027) 38
4.2.1 Global Pertussis Vaccine Sales Forecast by Type (2022-2027) 38
4.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2022-2027) 38
4.2.3 Global Pertussis Vaccine Price Forecast by Type (2022-2027) 39
5 GLOBAL PERTUSSIS VACCINE MARKET SIZE BY APPLICATION 40
5.1 Global Pertussis Vaccine Historic Market Review by Application (2016-2021) 40
5.1.1 Global Pertussis Vaccine Sales Market Share by Application (2016-2021) 40
5.1.2 Global Pertussis Vaccine Revenue Market Share by Application (2016-2021) 41
5.1.3 Global Pertussis Vaccine Price by Application (2016-2021) 42
5.2 Global Pertussis Vaccine Market Estimates and Forecasts by Application (2022-2027) 43
5.2.1 Global Pertussis Vaccine Sales Forecast by Application (2022-2027) 43
5.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2022-2027) 43
5.2.3 Global Pertussis Vaccine Price Forecast by Application (2022-2027) 44
6 NORTH AMERICA PERTUSSIS VACCINE MARKET FACTS & FIGURES 45
6.1 North America Pertussis Vaccine Sales by Company 45
6.1.1 North America Pertussis Vaccine Sales by Company (2016-2021) 45
6.1.2 North America Pertussis Vaccine Sales Market Share by Company (2016-2021) 45
6.2 North America Pertussis Vaccine Sales Breakdown by Type 45
6.2.1 North America Pertussis Vaccine Sales Breakdown by Type (2016-2021) 45
6.2.2 North America Pertussis Vaccine Sales Breakdown by Type (2022-2027) 46
6.3 North America Pertussis Vaccine Sales Breakdown by Application 47
6.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2016-2021) 47
6.3.2 North America Pertussis Vaccine Sales Breakdown by Application (2022-2027) 48
7 EUROPE PERTUSSIS VACCINE MARKET FACTS & FIGURES 49
7.1 Europe Pertussis Vaccine Sales by Company 49
7.1.1 Europe Pertussis Vaccine Sales by Company (2016-2021) 49
7.1.2 Europe Pertussis Vaccine Sales Market Share by Company (2016-2021) 49
7.2 Europe Pertussis Vaccine Sales Breakdown by Type 49
7.2.1 Europe Pertussis Vaccine Sales Breakdown by Type (2016-2021) 49
7.2.2 Europe Pertussis Vaccine Sales Breakdown by Type (2022-2027) 50
7.3 Europe Pertussis Vaccine Sales Breakdown by Application 51
7.3.1 Europe Pertussis Vaccine Sales Breakdown by Application (2016-2021) 51
7.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2022-2027) 52
8 CHINA PERTUSSIS VACCINE MARKET FACTS & FIGURES 53
8.1 China Pertussis Vaccine Sales by Company 53
8.1.1 China Pertussis Vaccine Sales by Company (2016-2021) 53
8.1.2 China Pertussis Vaccine Sales Market Share by Company (2016-2021) 53
8.2 China Pertussis Vaccine Sales Breakdown by Type 54
8.2.1 China Pertussis Vaccine Sales Breakdown by Type (2016-2021) 54
8.2.2 China Pertussis Vaccine Sales Breakdown by Type (2022-2027) 55
8.3 China Pertussis Vaccine Sales Breakdown by Application 55
8.3.1 China Pertussis Vaccine Sales Breakdown by Application (2016-2021) 55
8.3.2 China Pertussis Vaccine Sales Breakdown by Application (2022-2027) 56
9 JAPAN PERTUSSIS VACCINE MARKET FACTS & FIGURES 57
9.1 Japan Pertussis Vaccine Sales by Company 57
9.1.1 Japan Pertussis Vaccine Sales by Company (2016-2021) 57
9.1.2 Japan Pertussis Vaccine Sales Market Share by Company (2016-2021) 57
9.2 Japan Pertussis Vaccine Sales Breakdown by Type 57
9.2.1 Japan Pertussis Vaccine Sales Breakdown by Type (2016-2021) 57
9.2.2 Japan Pertussis Vaccine Sales Breakdown by Type (2022-2027) 58
9.3 Japan Pertussis Vaccine Sales Breakdown by Application 59
9.3.1 Japan Pertussis Vaccine Sales Breakdown by Application (2016-2021) 59
9.3.2 Japan Pertussis Vaccine Sales Breakdown by Application (2022-2027) 60
10 INDIA PERTUSSIS VACCINE MARKET FACTS & FIGURES 61
10.1 India Pertussis Vaccine Sales by Company 61
10.1.1 India Pertussis Vaccine Sales by Company (2016-2021) 61
10.1.2 India Pertussis Vaccine Sales Market Share by Company (2016-2021) 61
10.2 India Pertussis Vaccine Sales Breakdown by Type 61
10.2.1 India Pertussis Vaccine Sales Breakdown by Type (2016-2021) 61
10.2.2 India Pertussis Vaccine Sales Breakdown by Type (2022-2027) 62
10.3 India Pertussis Vaccine Sales Breakdown by Application 63
10.3.1 India Pertussis Vaccine Sales Breakdown by Application (2016-2021) 63
10.3.2 India Pertussis Vaccine Sales Breakdown by Application (2022-2027) 64
11 ASIA-PACIFIC OTHER PERTUSSIS VACCINE MARKET FACTS & FIGURES 65
11.1 Asia-Pacific Other Pertussis Vaccine Sales by Company 65
11.1.1 Asia-Pacific Other Pertussis Vaccine Sales by Company (2016-2021) 65
11.1.2 Asia-Pacific Other Pertussis Vaccine Sales Market Share by Company (2016-2021) 65
11.2 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Type 65
11.2.1 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Type (2016-2021) 65
11.2.2 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Type (2022-2027) 66
11.3 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Application 67
11.3.1 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Application (2016-2021) 67
11.3.2 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Application (2022-2027) 68
12 COMPANY PROFILES AND KEY FIGURES IN PERTUSSIS VACCINE BUSINESS 69
12.1 Sanofi Pasteur 69
12.1.1 Sanofi Pasteur Corporation Information 69
12.1.2 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 69
12.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered 70
12.2 GSK 71
12.2.1 GSK Corporation Information 71
12.2.2 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 71
12.2.3 GSK Pertussis Vaccine Products Offered 72
12.3 Mitsubishi Tanabe Pharma 72
12.3.1 Mitsubishi Tanabe Pharma Corporation Information 72
12.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 73
12.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered 73
12.4 KM Biologics 74
12.4.1 KM Biologics Corporation Information 74
12.4.2 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 74
12.4.3 KM Biologics Pertussis Vaccine Products Offered 75
12.5 Wuhan Institute of Biological Products 75
12.5.1 Wuhan Institute of Biological Products Corporation Information 75
12.5.2 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 76
12.5.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered 76
12.6 Walvax Biotechnology 77
12.6.1 Walvax Biotechnology Corporation Information 77
12.6.2 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 78
12.6.3 Walvax Biotechnology Pertussis Vaccine Products Offered 78
12.7 Chengdu Institute of Biological Products 79
12.7.1 Chengdu Institute of Biological Products Corporation Information 79
12.7.2 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 79
12.7.3 Chengdu Institute of Biological Products Pertussis Vaccine Products Offered 79
12.8 Minhai Biotechnology 80
12.8.1 Minhai Biotechnology Corporation Information 80
12.8.2 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 81
12.8.3 Minhai Biotechnology Pertussis Vaccine Products Offered 81
13 PERTUSSIS VACCINE MANUFACTURING COST ANALYSIS 82
13.1 Pertussis Vaccine Key Raw Materials Analysis 82
13.2 Proportion of Manufacturing Cost Structure 83
13.3 Manufacturing Process Analysis of Pertussis Vaccine 83
14 MARKETING CHANNEL AND DISTRIBUTORS 85
14.1 Marketing Channel 85
14.2 Pertussis Vaccine Distributors List 86
15 MARKET DYNAMICS 89
15.1 Pertussis Vaccine Market Trends 89
15.2 Pertussis Vaccine Opportunities and Drivers 89
15.3 Pertussis Vaccine Market Challenges 89
15.4 Porter's Five Forces Analysis 90
16 RESEARCH FINDINGS AND CONCLUSION 91
17 APPENDIX 92
17.1 Research Methodology 92
17.1.1 Methodology/Research Approach 92
17.1.2 Data Source 95
17.2 Author Details 98
17.3 Disclaimer 98
List of Tables
Table 1. Global Pertussis Vaccine Revenue (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) 2
Table 2. Global Pertussis Vaccine Revenue (US$ Million) Comparison by Application (2016 & 2021 & 2027) 4
Table 3. Global Market Pertussis Vaccine Market Size (US$ Million) by Region:2016 VS 2021 &2027 11
Table 4. Global Pertussis Vaccine Sales (Million Doses) by Region (2016-2021) 12
Table 5. Global Pertussis Vaccine Sales Market Share by Region (2016-2021) 12
Table 6. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Region (2016-2021) 13
Table 7. Global Pertussis Vaccine Revenue Share by Region (2016-2021) 14
Table 8. Global Pertussis Vaccine Sales (Million Doses) Forecast by Region (2022-2027) 15
Table 9. Global Pertussis Vaccine Sales Market Share Forecast by Region (2022-2027) 15
Table 10. Global Pertussis Vaccine Revenue (US$ Million) Forecast by Region (2022-2027) 16
Table 11. Global Pertussis Vaccine Revenue Share Forecast by Region (2022-2027) 17
Table 12. Global Pertussis Vaccine Sales (Million Doses) of Key Companies (2016-2021) 30
Table 13. Global Pertussis Vaccine Sales Share by Company (2016-2021) 30
Table 14. Global Pertussis Vaccine Revenue (US$ Million) by Company (2016-2021) 32
Table 15. Global Pertussis Vaccine Revenue Share by Company (2016-2021) 32
Table 16. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2020) 33
Table 17. Global Market Pertussis Vaccine Average Price (USD/Dose) of Key Company (2016-2021) 34
Table 18. Pertussis Vaccine Manufacturers Headquarters 34
Table 19. Global Pertussis Vaccine Sales (Million Doses) by Type (2016-2021) 35
Table 20. Global Pertussis Vaccine Sales Share by Type (2016-2021) 35
Table 21. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Type (2016-2021) 36
Table 22. Global Pertussis Vaccine Price (USD/Dose) by Type (2016-2021) 37
Table 23. Global Pertussis Vaccine Sales (Million Doses) by Type (2022-2027) 38
Table 24. Global Pertussis Vaccine Sales Share by Type (2022-2027) 38
Table 25. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) 38
Table 26. Global Pertussis Vaccine Revenue Share by Type (2022-2027) 38
Table 27. Global Pertussis Vaccine Price (USD/Dose) by Type (2022-2027) 39
Table 28. Global Pertussis Vaccine Sales (Million Doses) by Application (2016-2021) 40
Table 29. Global Pertussis Vaccine Sales Share by Application (2016-2021) 40
Table 30. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Application (2016-2021) 41
Table 31. Global Pertussis Vaccine Price (USD/Dose) by Application (2016-2021) 42
Table 32. Global Pertussis Vaccine Sales (Million Doses) by Application (2022-2027) 43
Table 33. Global Pertussis Vaccine Sales Share by Application (2022-2027) 43
Table 34. Global Pertussis Vaccine Revenue (US$ Million) Market Share by Application (2022-2027) 43
Table 35. Global Pertussis Vaccine Revenue Share by Application (2022-2027) 43
Table 36. Global Pertussis Vaccine Price (USD/Dose) by Application (2022-2027) 44
Table 37. North America Pertussis Vaccine Sales by Company (2016-2021) & (Million Doses) 45
Table 38. North America Pertussis Vaccine Sales Market Share by Company (2016-2021) 45
Table 39. North America Pertussis Vaccine Sales by Type (2016-2021) & (Million Doses) 45
Table 40. North America Pertussis Vaccine Sales by Type (2022-2027) & (Million Doses) 46
Table 41. North America Pertussis Vaccine Sales by Application (2016-2021) & (Million Doses) 47
Table 42. North America Pertussis Vaccine Sales by Application (2022-2027) & (Million Doses) 48
Table 43. Europe Pertussis Vaccine Sales by Company (2016-2021) & (Million Doses) 49
Table 44. Europe Pertussis Vaccine Sales Market Share by Company (2016-2021) 49
Table 45. Europe Pertussis Vaccine Sales by Type (2016-2021) & (Million Doses) 49
Table 46. Europe Pertussis Vaccine Sales by Type (2022-2027) & (Million Doses) 50
Table 47. Europe Pertussis Vaccine Sales by Application (2016-2021) & (Million Doses) 51
Table 48. Europe Pertussis Vaccine Sales by Application (2022-2027) & (Million Doses) 52
Table 49. China Pertussis Vaccine Sales by Company (2016-2021) & (Million Doses) 53
Table 50. China Pertussis Vaccine Sales Market Share by Company (2016-2021) 53
Table 51. China Pertussis Vaccine Sales by Type (2016-2021) & (Million Doses) 54
Table 52. China Pertussis Vaccine Sales by Type (2022-2027) & (Million Doses) 55
Table 53. China Pertussis Vaccine Sales by Application (2016-2021) & (Million Doses) 55
Table 54. China Pertussis Vaccine Sales by Application (2022-2027) & (Million Doses) 56
Table 55. Japan Pertussis Vaccine Sales by Company (2016-2021) & (Million Doses) 57
Table 56. Japan Pertussis Vaccine Sales Market Share by Company (2016-2021) 57
Table 57. Japan Pertussis Vaccine Sales by Type (2016-2021) & (Million Doses) 57
Table 58. Japan Pertussis Vaccine Sales by Type (2022-2027) & (Million Doses) 58
Table 59. Japan Pertussis Vaccine Sales by Application (2016-2021) & (Million Doses) 59
Table 60. Japan Pertussis Vaccine Sales by Application (2022-2027) & (Million Doses) 60
Table 61. India Pertussis Vaccine Sales by Company (2016-2021) & (Million Doses) 61
Table 62. India Pertussis Vaccine Sales Market Share by Company (2016-2021) 61
Table 63. India Pertussis Vaccine Sales by Type (2016-2021) & (Million Doses) 61
Table 64. India Pertussis Vaccine Sales by Type (2022-2027) & (Million Doses) 62
Table 65. India Pertussis Vaccine Sales by Application (2016-2021) & (Million Doses) 63
Table 66. India Pertussis Vaccine Sales by Application (2022-2027) & (Million Doses) 64
Table 67. Asia-Pacific Other Pertussis Vaccine Sales by Company (2016-2021) & (Million Doses) 65
Table 68. Asia-Pacific Other Pertussis Vaccine Sales Market Share by Company (2016-2021) 65
Table 69. Asia-Pacific Other Pertussis Vaccine Sales by Type (2016-2021) & (Million Doses) 65
Table 70. Asia-Pacific Other Pertussis Vaccine Sales by Type (2022-2027) & (Million Doses) 66
Table 71. Asia-Pacific Other Pertussis Vaccine Sales by Application (2016-2021) & (Million Doses) 67
Table 72. Asia-Pacific Other Pertussis Vaccine Sales by Application (2022-2027) & (Million Doses) 68
Table 73. Sanofi Pasteur Corporation Information 69
Table 74. Sanofi Pasteur Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 69
Table 75. Sanofi Pasteur Pertussis Vaccine Product 70
Table 76. GSK Corporation Information 71
Table 77. GSK Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 71
Table 78. GSK Pertussis Vaccine Product 72
Table 79. Mitsubishi Tanabe Pharma Corporation Information 72
Table 80. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 73
Table 81. Mitsubishi Tanabe Pharma Pertussis Vaccine Product 73
Table 82. KM Biologics Corporation Information 74
Table 83. KM Biologics Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 74
Table 84. KM Biologics Pertussis Vaccine Product 75
Table 85. Wuhan Institute of Biological Products Corporation Information 75
Table 86. Wuhan Institute of Biological Products Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 76
Table 87. Wuhan Institute of Biological Products Pertussis Vaccine Product 76
Table 88. Walvax Biotechnology Corporation Information 77
Table 89. Walvax Biotechnology Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 78
Table 90. Walvax Biotechnology Pertussis Vaccine Product 78
Table 91. Chengdu Institute of Biological Products Corporation Information 79
Table 92. Chengdu Institute of Biological Products Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 79
Table 93. Chengdu Institute of Biological Products Pertussis Vaccine Product 79
Table 94. Minhai Biotechnology Corporation Information 80
Table 95. Minhai Biotechnology Pertussis Vaccine Sales (Million Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 81
Table 96. Minhai Biotechnology Pertussis Vaccine Product 81
Table 97. Key Suppliers of Raw Materials 82
Table 98. Pertussis Vaccine Distributors List 86
Table 99. Pertussis Vaccine Market Trends 89
Table 100. Pertussis Vaccine Opportunities and Drivers 89
Table 101. Pertussis Vaccine Market Challenges 89
Table 102. Research Programs/Design for This Report 92
Table 103. Key Data Information from Secondary Sources 95
Table 104. Key Data Information from Primary Sources 97
List of Figures
Figure 1. Pertussis Vaccine Product Picture 1
Figure 2. Global Pertussis Vaccine Revenue Market Share by Type in 2021 2
Figure 3. Acellular Vaccines Product Picture 3
Figure 4. Whole-cell Vaccines Product Picture 4
Figure 5. Global Pertussis Vaccine Revenue Market Share by Application in 2021 5
Figure 6. 12 Months Below Examples 6
Figure 7. 12 Months Above Examples 7
Figure 8. Global Pertussis Vaccine Sales Growth Rate (2016-2027) & (US$ Million) 8
Figure 9. Global Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 9
Figure 10. Global Pertussis Vaccine Price Trends Growth Rate (2016-2027) & (USD/Dose) 10
Figure 11. Global Pertussis Vaccine Sales Market Share by Region: 2020 13
Figure 12. Global Pertussis Vaccine Revenue Market Share by Region: 2020 14
Figure 13. Global Pertussis Vaccine Sales Market Share by Region: 2027 16
Figure 14. Global Pertussis Vaccine Revenue Market Share by Region: 2027 17
Figure 15. North America Pertussis Vaccine Revenue (US$ Million) Growth Rate (2016-2027) 18
Figure 16. North America Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 19
Figure 17. Europe Pertussis Vaccine Revenue (US$ Million) Growth Rate (2016-2027) 20
Figure 18. Europe Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 21
Figure 19. China Pertussis Vaccine Revenue (US$ Million) Growth Rate (2016-2027) 22
Figure 20. China Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 23
Figure 21. Japan Pertussis Vaccine Revenue (US$ Million) Growth Rate (2016-2027) 24
Figure 22. Japan Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 25
Figure 23. India Pertussis Vaccine Revenue (US$ Million) Growth Rate (2016-2027) 26
Figure 24. India Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 27
Figure 25. Asia-Pacific Other Pertussis Vaccine Revenue (US$ Million) Growth Rate (2016-2027) 28
Figure 26. Asia-Pacific Other Pertussis Vaccine Sales (Million Doses) Growth Rate (2016-2027) 29
Figure 27. Global Pertussis Vaccine Sales Share by Company: 2020 31
Figure 28. Global Pertussis Vaccine Revenue Share by Company: 2020 33
Figure 29. Global Pertussis Vaccine Sales Share by Type in 2020 36
Figure 30. Global Pertussis Vaccine Revenue Share by Type (2016-2021) 36
Figure 31. Global Pertussis Vaccine Revenue Share by Type in 2020 37
Figure 32. Global Pertussis Vaccine Sales Share by Application in 2020 41
Figure 33. Global Pertussis Vaccine Revenue Share by Application (2016-2021) 41
Figure 34. Global Pertussis Vaccine Revenue Share by Application in 2020 42
Figure 35. North America Pertussis Vaccine Sales Market Share by Type in 2020 46
Figure 36. North America Pertussis Vaccine Sales Market Share by Application in 2020 47
Figure 37. Europe Pertussis Vaccine Sales Market Share by Type in 2020 50
Figure 38. Europe Pertussis Vaccine Sales Market Share by Application in 2020 51
Figure 39. China Pertussis Vaccine Sales Market Share by Type in 2020 54
Figure 40. China Pertussis Vaccine Sales Market Share by Application in 2020 56
Figure 41. Japan Pertussis Vaccine Sales Market Share by Type in 2020 58
Figure 42. Japan Pertussis Vaccine Sales Market Share by Application in 2020 59
Figure 43. India Pertussis Vaccine Sales Market Share by Type in 2020 62
Figure 44. India Pertussis Vaccine Sales Market Share by Application in 2020 63
Figure 45. Asia-Pacific Other Pertussis Vaccine Sales Market Share by Type in 2020 66
Figure 46. Asia-Pacific Other Pertussis Vaccine Sales Market Share by Application in 2020 67
Figure 47. Manufacturing Cost Structure of Pertussis Vaccine 83
Figure 48. Channels of Distribution 86
Figure 49. Distributors Profiles 87
Figure 50. Porter's Five Forces Analysis 90
Figure 51. Bottom-up and Top-down Approaches for This Report 94
Figure 52. Data Triangulation 95
Figure 53. Key Executives Interviewed 97

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs